Effects of dihydroartiminisin on proliferation and phosphorylation of mitogen-activated protein kinase in epithelial ovarian cancer cell lines
- VernacularTitle:双氢青蒿素对卵巢上皮性癌细胞体外增殖及有丝分裂原激活的蛋白激酶磷酸化水平的影响
- Author:
Xianjie TAN
;
Plouet JEAN
;
Jinghe LANG
;
Ming WU
;
Keng SHEN
- Publication Type:Journal Article
- Keywords:
Ovarian neoplasms;
Tumor cells,cultured;
Cell proliferation;
Artemisinins;
Mitogen-activated protein kinases;
Phosphorylation
- From:
Chinese Journal of Obstetrics and Gynecology
2008;43(9):662-665
- CountryChina
- Language:Chinese
-
Abstract:
Objective To determine the effect of dihydroartiminisin on the proliferation and phosphorylation of mitogen-activated protein kinase (MAPK) in SKOV3 and OVCAR3 ovarian cancer cell lines.Methods Methyl thiazolyl tetrazolium assay was performed to evaluate the anti-proliferative effect of dihydroartiminisin in SKOV3 and OVCAR3 cells,and Western blot was used to determine its effect on phosphorylation level of MAPK,including extra-cell regulated kinase (ERK)1/2 and p38 protein kinase,in the two cell lines.Results Dihydroartiminisin inhibited the proliferation of ovarian cancer cells in vitro,with a mean of 50% inhibition concentration (IC50) at 72 h of (9.0 ±1.4) μmol/L for SKOV3 and (5.5 ±1.2)μmol/L for OVCAR3 respectively. Compared to cells without dihydroartiminisin treatment,phosphorylation level of ERK 1/2 in SKOV3 and OVCAR3 cells treated with dihydroartiminisin decreased by 64.2% and 75.3% respectively (P<0.05),while phosphorylation of p38 protein kinase in SKOV3 and OVCAR3 only decreased by 8.5% and 6.4% respectively (P >0.05).Conclusion Dihydroartiminisin can inhibit the proliferation of ovarian cancer cell in vitro, probably through down-regulation of the phosphorylation of ERK 1/2 in ovarian cancer cells.